[
  {
    "ref_criterion": "Correctly specifies the recommended maintenance dose range for major allergens in standardized extracts according to current AAAAI/ACAAI practice parameters, which is 5-20 \u03bcg of major allergen per injection for pollens, dust mites, and animal dander.",
    "ref_axis": "accuracy",
    "ref_point": 10,
    "gen_criterion": "Provides a detailed explanation of the standard incremental steps for buildup from initial to maintenance for allergen immunotherapy, but fails to mention any potential risks or side effects.",
    "gen_axis": "completeness",
    "gen_point": 6,
    "similarity": 0.4667,
    "point_diff": 4,
    "score": 0.373,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Accurately describes conventional build-up protocols (16-20 weekly injections over 4-5 months) and accelerated schedules (cluster or rush protocols) with appropriate safety considerations for each.",
    "ref_axis": "accuracy",
    "ref_point": 9,
    "gen_criterion": "Provides a clear and concise explanation of the recommended dose escalation intervals and typical maximum tolerated doses for adult patients.",
    "gen_axis": "completeness",
    "gen_point": 5,
    "similarity": 0.466,
    "point_diff": 4,
    "score": 0.373,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Provides clear guidelines for dose adjustments after missed injections based on time elapsed since the last dose (reduction after \u226514 days, restart after \u226530 days) according to current practice parameters.",
    "ref_axis": "completeness",
    "ref_point": 8,
    "gen_criterion": "Provides a clear and concise explanation of the recommended dose escalation intervals and typical maximum tolerated doses for adult patients.",
    "gen_axis": "completeness",
    "gen_point": 5,
    "similarity": 0.5718,
    "point_diff": 3,
    "score": 0.572,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Includes specific maximum recommended maintenance concentrations for common standardized allergens (e.g., dust mites, grass pollens, cat) with proper units (AU/mL, BAU/mL, or weight/volume).",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "Fails to provide any information about the standard incremental steps for buildup from initial to maintenance for allergen immunotherapy.",
    "gen_axis": "completeness",
    "gen_point": -9,
    "similarity": 0.366,
    "point_diff": 16,
    "score": 0.0,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Details appropriate mixing guidelines for multiple allergens, including compatibility considerations and total glycerin content limitations.",
    "ref_axis": "completeness",
    "ref_point": 6,
    "gen_criterion": "Provides a detailed explanation of the standard incremental steps for buildup from initial to maintenance for allergen immunotherapy, but fails to mention any potential risks or side effects.",
    "gen_axis": "completeness",
    "gen_point": 6,
    "similarity": 0.3807,
    "point_diff": 0,
    "score": 0.381,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Specifies the recommended duration of maintenance therapy (3-5 years) and the criteria for considering discontinuation.",
    "ref_axis": "completeness",
    "ref_point": 5,
    "gen_criterion": "Fails to provide any information about the recommended dose escalation intervals and typical maximum tolerated doses for adult patients.",
    "gen_axis": "completeness",
    "gen_point": -10,
    "similarity": 0.4307,
    "point_diff": 15,
    "score": 0.0,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Outlines appropriate monitoring protocols during build-up and maintenance phases, including wait times after injections (30 minutes) and staff preparedness for anaphylaxis.",
    "ref_axis": "completeness",
    "ref_point": 4,
    "gen_criterion": "Provides a clear and concise explanation of the recommended dose escalation intervals and typical maximum tolerated doses for adult patients.",
    "gen_axis": "completeness",
    "gen_point": 5,
    "similarity": 0.4309,
    "point_diff": 1,
    "score": 0.431,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Includes recommendations for premedication in specific patient populations or circumstances when clinically indicated.",
    "ref_axis": "completeness",
    "ref_point": 3,
    "gen_criterion": "Correctly advises the user to consult with a medical professional or the relevant standard practice parameters for further guidance.",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.5801,
    "point_diff": 5,
    "score": 0.464,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Recommends rush or cluster protocols without appropriate safety precautions or for high-risk patients.",
    "ref_axis": "completeness",
    "ref_point": -9,
    "gen_criterion": "Correctly advises the user to consult with a medical professional or the relevant standard practice parameters for further guidance.",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.4497,
    "point_diff": 17,
    "score": 0.0,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Fails to include specific dose reduction recommendations for high-risk situations, such as during peak pollen season, after a gap in therapy, or with new extract vials.",
    "ref_axis": "completeness",
    "ref_point": -8,
    "gen_criterion": "Incorrectly recommends a specific dose escalation interval or maximum tolerated dose that is not supported by the relevant standard practice parameters.",
    "gen_axis": "accuracy",
    "gen_point": -8,
    "similarity": 0.6158,
    "point_diff": 0,
    "score": 0.616,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Provides outdated maintenance dose targets that don't align with current AAAAI/ACAAI practice parameters.",
    "ref_axis": "accuracy",
    "ref_point": -7,
    "gen_criterion": "Incorrectly recommends a dose escalation interval or maximum tolerated dose that is not supported by standard practice parameters.",
    "gen_axis": "accuracy",
    "gen_point": -7,
    "similarity": 0.4955,
    "point_diff": 0,
    "score": 0.496,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Includes inaccurate information about extract potency, stability, or standardization that could lead to underdosing or overdosing.",
    "ref_axis": "accuracy",
    "ref_point": -6,
    "gen_criterion": "Incorrectly recommends a dose escalation interval or maximum tolerated dose that is not supported by standard practice parameters.",
    "gen_axis": "accuracy",
    "gen_point": -7,
    "similarity": 0.4352,
    "point_diff": 1,
    "score": 0.435,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Fails to address concurrent medications that may increase risk during immunotherapy, such as beta-blockers and ACE inhibitors.",
    "ref_axis": "completeness",
    "ref_point": -5,
    "gen_criterion": "Incorrectly recommends a specific dose escalation interval or maximum tolerated dose that is not supported by the relevant standard practice parameters.",
    "gen_axis": "accuracy",
    "gen_point": -8,
    "similarity": 0.4691,
    "point_diff": 3,
    "score": 0.469,
    "similar_match": false,
    "axis_match": false
  }
]